Insider Transactions in Q2 2024 at Genelux Corp (GNLX)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 24
2024
|
Caroline Jewett Head of Quality |
SELL
Open market or private sale
|
Direct |
4,961
-23.47%
|
$9,922
$2.12 P/Share
|
|
Jun 24
2024
|
Sean Ryder General Counsel |
SELL
Open market or private sale
|
Direct |
5,496
-22.09%
|
$10,992
$2.12 P/Share
|
|
Jun 24
2024
|
Tony Yu VP, Clinical Trial Operations |
SELL
Open market or private sale
|
Direct |
6,849
-38.66%
|
$13,698
$2.12 P/Share
|
|
May 29
2024
|
Mary Mirabelli |
BUY
Open market or private purchase
|
Direct |
8,000
+39.1%
|
-
|
|
May 29
2024
|
John Thomas |
BUY
Open market or private purchase
|
Direct |
2,500
+0.53%
|
-
|
|
May 29
2024
|
John W Smither |
BUY
Open market or private purchase
|
Direct |
6,250
+32.18%
|
-
|
|
May 29
2024
|
James L Tyree |
BUY
Open market or private purchase
|
Direct |
6,250
+39.16%
|
-
|
|
May 29
2024
|
Lourie S. Zak Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
31,250
+50.0%
|
-
|
|
May 29
2024
|
Sean Ryder General Counsel |
BUY
Open market or private purchase
|
Direct |
10,000
+48.61%
|
-
|
|
May 29
2024
|
Ralph Smalling Head of Regulatory |
BUY
Open market or private purchase
|
Direct |
1,250
+8.58%
|
-
|
|
May 29
2024
|
Thomas Zindrick President and CEO |
BUY
Open market or private purchase
|
Indirect |
200,000
+50.0%
|
-
|
|
May 29
2024
|
Tony Yu VP, Clinical Trial Operations |
BUY
Open market or private purchase
|
Direct |
2,500
+50.0%
|
-
|
|
May 15
2024
|
Aladar Szalay |
SELL
Open market or private sale
|
Indirect |
17,094
-1.48%
|
$51,282
$3.66 P/Share
|
|
May 14
2024
|
Aladar Szalay |
SELL
Open market or private sale
|
Indirect |
15,426
-1.32%
|
$46,278
$3.58 P/Share
|
|
May 13
2024
|
Aladar Szalay |
SELL
Open market or private sale
|
Indirect |
3,446
-0.29%
|
$10,338
$3.62 P/Share
|
|
May 08
2024
|
Aladar Szalay |
SELL
Open market or private sale
|
Indirect |
13,919
-1.17%
|
$41,757
$3.82 P/Share
|
|
May 07
2024
|
Aladar Szalay |
SELL
Open market or private sale
|
Indirect |
6,025
-0.5%
|
$18,075
$3.67 P/Share
|
|
May 01
2024
|
Aladar Szalay |
SELL
Open market or private sale
|
Indirect |
33,061
-2.69%
|
$99,183
$3.3 P/Share
|
|
Apr 30
2024
|
Aladar Szalay |
SELL
Open market or private sale
|
Indirect |
20,535
-1.64%
|
$61,605
$3.12 P/Share
|
|
Apr 29
2024
|
Aladar Szalay |
SELL
Open market or private sale
|
Indirect |
6,403
-0.51%
|
$19,209
$3.25 P/Share
|
|
Apr 24
2024
|
Aladar Szalay |
SELL
Open market or private sale
|
Indirect |
8,064
-0.64%
|
$24,192
$3.5 P/Share
|
|
Apr 23
2024
|
Aladar Szalay |
SELL
Open market or private sale
|
Indirect |
22,000
-1.71%
|
$66,000
$3.49 P/Share
|
|
Apr 22
2024
|
Aladar Szalay |
SELL
Open market or private sale
|
Indirect |
14,331
-1.1%
|
$42,993
$3.53 P/Share
|
|
Apr 17
2024
|
Aladar Szalay |
SELL
Open market or private sale
|
Indirect |
22,737
-1.72%
|
$68,211
$3.71 P/Share
|
|
Apr 16
2024
|
Aladar Szalay |
SELL
Open market or private sale
|
Indirect |
48,683
-3.55%
|
$146,049
$3.53 P/Share
|